Imatinib Mesylate
IkT-001Pro-501
Phase 1 small_molecule completed
Quick answer
Imatinib Mesylate for CML is a Phase 1 program (small_molecule) at Inhibikase Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibikase Therapeutics
- Indication
- CML
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed